Literature DB >> 9562967

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels.

F Belfiore1, S Iannello, G Volpicelli.   

Abstract

Insulin Sensitivity Indices for glycemia [ISI(gly)] and blood FFA [ISI(ffa)] can be calculated with the formulas: ISI(gly) = 2/[(INSp x GLYp) + 1], and ISI(ffa) = 2/[(INSp x FFAp) + 1], where INSp, GLYp and FFAp = insulinemic, glycemic, and FFA areas during OGTT (75 g glucose) of the person under study, simplified by considering only data at 0 and 2 h (0-2 h areas), according to WHO criteria or, better, at 0, 1 and 2 h (0-1-2 h areas). Expressed as unit/ volume.h-1, 0-1-2 h area is equal to 1/2 value at 0 min + value at 1 h + 1/2 value at 2 h, while 0-2 h area is equal to value at 0 + value at 2 h. Instead of areas, basal levels can also be used. Basal levels and areas are expressed taking the mean normal value as unit, so that in normal subjects ISI(gly) and ISI(ffa) are always around 1, with maximal variations between 0 and 2. Each laboratory should have its normal reference values for basal levels and OGTT areas. However, reliable mean normal values were selected from literature. Based on meta-analysis of published data, ISI(gly) and ISI(ffa) were reduced in subjects who were overweight and/or IGT and in NIDDM patients and their relatives. Moreover, correlation of ISI(gly) with the euglycemic clamp data was significant. However, it should be stressed that the clamp procedure is performed under artificially induced steady-state whereas ISI(gly) and ISI(ffa) are obtained under rather physiological conditions, with hormonal and metabolic variables unmodified, thus being suitable to assess whole-body insulin sensitivity in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562967     DOI: 10.1006/mgme.1997.2658

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  51 in total

1.  Limitations in surrogate measures of insulin resistance.

Authors:  Thomas A Buchanan; Richard M Watanabe; Anny H Xiang
Journal:  J Clin Endocrinol Metab       Date:  2010-11       Impact factor: 5.958

2.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

Review 3.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

4.  Adipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance.

Authors:  Karen Hershkop; Omri Besor; Nicola Santoro; Bridget Pierpont; Sonia Caprio; Ram Weiss
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

Review 5.  Estimation of insulin sensitivity in children: methods, measures and controversies.

Authors:  Rebecca J Brown; Jack A Yanovski
Journal:  Pediatr Diabetes       Date:  2014-04-23       Impact factor: 4.866

6.  Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.

Authors:  Erik Ingelsson; Claudia Langenberg; Marie-France Hivert; Inga Prokopenko; Valeriya Lyssenko; Josée Dupuis; Reedik Mägi; Stephen Sharp; Anne U Jackson; Themistocles L Assimes; Peter Shrader; Joshua W Knowles; Björn Zethelius; Fahim A Abbasi; Richard N Bergman; Antje Bergmann; Christian Berne; Michael Boehnke; Lori L Bonnycastle; Stefan R Bornstein; Thomas A Buchanan; Suzannah J Bumpstead; Yvonne Böttcher; Peter Chines; Francis S Collins; Cyrus C Cooper; Elaine M Dennison; Michael R Erdos; Ele Ferrannini; Caroline S Fox; Jürgen Graessler; Ke Hao; Bo Isomaa; Karen A Jameson; Peter Kovacs; Johanna Kuusisto; Markku Laakso; Claes Ladenvall; Karen L Mohlke; Mario A Morken; Narisu Narisu; David M Nathan; Laura Pascoe; Felicity Payne; John R Petrie; Avan A Sayer; Peter E H Schwarz; Laura J Scott; Heather M Stringham; Michael Stumvoll; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Jaakko Tuomilehto; Anke Tönjes; Timo T Valle; Gordon H Williams; Lars Lind; Inês Barroso; Thomas Quertermous; Mark Walker; Nicholas J Wareham; James B Meigs; Mark I McCarthy; Leif Groop; Richard M Watanabe; Jose C Florez
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

7.  Erythrocyte fatty acid composition and insulin sensitivity in daughters of Type 2 diabetic patients and women with no family history of diabetes.

Authors:  G Ntali; C Koutsari; K Karakike; P Makras; F Skopouli; M Mc Milan; C Slater; S Higgins; A Zampelas; D Malkova
Journal:  J Endocrinol Invest       Date:  2009-12-04       Impact factor: 4.256

Review 8.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

9.  Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting.

Authors:  Lorenzo M Donini; Massimo Cuzzolaro; Lucio Gnessi; Carla Lubrano; Silvia Migliaccio; Antonio Aversa; Alessandro Pinto; Andrea Lenzi
Journal:  Eat Weight Disord       Date:  2014-03-01       Impact factor: 4.652

10.  Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.

Authors:  E Faloia; P Canibus; C Gatti; F Frezza; M Santangelo; G G M Garrapa; M Boscaro
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.